Pepto-Bismol Original Strength Interactions
There are 133 drugs known to interact with Pepto-Bismol Original Strength (bismuth subsalicylate), along with 2 disease interactions. Of the total drug interactions, 11 are major, 113 are moderate, and 9 are minor.
- View all 133 medications that may interact with Pepto-Bismol Original Strength
- View Pepto-Bismol Original Strength disease interactions (2)
Most frequently checked interactions
View interaction reports for Pepto-Bismol Original Strength (bismuth subsalicylate) and the medicines listed below.
- acetaminophen
- Aleve (naproxen)
- amlodipine
- atorvastatin
- Benadryl (diphenhydramine)
- cephalexin
- Claritin (loratadine)
- CoQ10 (ubiquinone)
- cyclobenzaprine
- duloxetine
- Eliquis (apixaban)
- famotidine
- Fish Oil (omega-3 polyunsaturated fatty acids)
- gabapentin
- ibuprofen
- levothyroxine
- lisinopril
- magnesium oxide
- meclizine
- melatonin
- metformin
- MiraLAX (polyethylene glycol 3350)
- omeprazole
- ondansetron
- prednisone
- turmeric
- Tylenol (acetaminophen)
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
Pepto-Bismol Original Strength disease interactions
There are 2 disease interactions with Pepto-Bismol Original Strength (bismuth subsalicylate) which include:
More about Pepto-Bismol Original Strength (bismuth subsalicylate)
- Compare alternatives
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: antidiarrheals
- Breastfeeding
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.